日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

GLP-1 receptor agonists or SGLT2-inhibitors? Evaluation of a personalized treatment algorithm for individuals with type 2 diabetes: a registry-based cohort study

GLP-1受体激动剂还是SGLT2抑制剂?评估2型糖尿病患者的个体化治疗方案:一项基于注册登记的队列研究

Mori, Tim; Kuß, Oliver; Mader, Julia K; Naudorf, Michael; Seufert, Jochen; Holl, Reinhard W; Lanzinger, Stefanie; Grimsmann, Julia M

Heterogeneity in response to GLP-1 receptor agonists in type 2 diabetes in real-world clinical practice: insights from the DPV register - an IMI-SOPHIA study

真实世界临床实践中2型糖尿病患者对GLP-1受体激动剂反应的异质性:来自DPV注册研究的启示——一项IMI-SOPHIA研究

Heni, Martin; Frühwald, Lisa; Karges, Wolfram; Naudorf, Michael; Niemöller, Kathrin; Pagnia, Frank; Reindel, Jörg; Seufert, Jochen; Ufer, Gisa; Wagner, Christian; Holl, Reinhard W; Prinz, Nicole